CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

48.77 -0.62 (-1.26%)

Delayed Quote Updated: 3:21 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

37 38 Next >

3 Reasons to Buy CRISPR Therapeutics Stock, and 1 Reason to Sell ↗

August 12, 2023

This company is in a critical period, and it could soon grow significantly.

Via The Motley Fool

Ready to Buy the Dip? CRISPR Therapeutics Stock Is a Smart Buy ↗

August 11, 2023

Its shares tumbled due to factors outside its control, but the biotech still has substantial long-term potential.

Via The Motley Fool

Cathie Wood Buys Roblox, Palantir Dips — Ark Invest Seizes Buying Opportunities Following Earnings Reports ↗

August 09, 2023

Via Benzinga

The 3 Best Biotech Stocks to Buy in August ↗

August 09, 2023

Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news.

Via InvestorPlace

2 Supercharged Growth Stocks That Could Make You Richer ↗

August 09, 2023

These two biotechs are poised for a sustained period of growth.

Via The Motley Fool

2 Great Stocks Under $100 to Buy and Hold for 10 Years ↗

August 09, 2023

Neither has performed well over the past year, but investors would do well to focus on the longer term.

Via The Motley Fool

Why CRISPR Therapeutics Stock Is Jumping Today ↗

August 08, 2023

Analysts continue to like this gene-editing stock.

Via The Motley Fool

1 No-Brainer Cathie Wood Stock to Buy Hand Over Fist in August ↗

August 02, 2023

Crispr Therapeutics could be incredibly undervalued right now.

Via The Motley Fool

The Latest Analyst Ratings for CRISPR Therapeutics ↗

July 25, 2023

Via Benzinga

Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 08, 2023

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...

Via Benzinga

2 Magnificient Growth Stocks to Buy in July ↗

July 13, 2023

These two growth stocks might be incredibly undervalued right now.

Via The Motley Fool

Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday ↗

August 08, 2023

U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to...

Via Benzinga

3 Biotech Stocks That Analysts Are Drooling Over ↗

August 07, 2023

With the medical science realm representing one of the most complex markets, these top analyst biotech picks can be worth your time.

Via InvestorPlace

3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now ↗

August 02, 2023

Biotech stocks can be a lucrative investment opportunity, these three biotech stocks to buy now are among analyst favorites.

Via InvestorPlace

Vertex Pharma Raises Annual Forecast On Strong Uptake For Cystic Fibrosis Drug, Analysts Says Investors' Focus On Non-CF Pipeline ↗

August 02, 2023

Vertex Pharmaceuticals Inc's (NASDAQ: VRTX) Q2 sales increased 14% to $2.49 billion, beating the consensus of $2.41 bill

Via Benzinga

3 Hidden Penny Stocks That Could Turn $100 into $10,000 ↗

July 31, 2023

These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts.

Via InvestorPlace

These 2 Stocks Are Heading for a Big Moment. Time to Buy? ↗

July 31, 2023

Both stocks have climbed in the double digits this year.

Via The Motley Fool

This 1 Innovation Could Make These 2 Biotechs Soar by 2030 ↗

July 22, 2023

Simplifying the cell therapy manufacturing process could be worth a lot of money.

Via The Motley Fool

2 Soaring Stocks With More Upside Potential ↗

July 21, 2023

Are these mid-cap stocks giants in the making?

Via The Motley Fool

Is Now a Good Time to Buy CRISPR Therapeutics? ↗

July 21, 2023

CRISPR shares have climbed more than 40% this year.

Via The Motley Fool

3 Tech Stocks to Watch for Groundbreaking Innovations in 2030 ↗

July 19, 2023

If you’re a speculative investor here are three companies that are on the leading edge of what may be groundbreaking innovations by 2030.

Via InvestorPlace

2 Monster Stocks to Buy Without Any Hesitation ↗

July 17, 2023

These players each bring in billions of dollars in earnings every year.

Via The Motley Fool

Cathie Wood Is Buying These 3 Growth Stocks Hand Over Fist. Should You? ↗

July 15, 2023

The captain of innovation-focused investing can't seem to get enough of these beaten-down growth stocks.

Via The Motley Fool

3 Pharma Stocks That AI is Loving in July ↗

July 13, 2023

Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.

Via InvestorPlace

2 No-Brainer Healthcare Stocks to Buy With $100 Right Now ↗

July 13, 2023

These stocks may not stay this low for long.

Via The Motley Fool

3 Top Biotech Stocks Defying the Bear Market ↗

July 13, 2023

Each has the potential to dramatically outperform the market.

Via The Motley Fool

3 Biotech Stocks to Buy for Long-Term Gains

July 13, 2023

The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.

Via MarketBeat

Topics ETFs Economy

3 Things About Vertex Pharmaceuticals That Smart Investors Know ↗

July 12, 2023

Vertex shares have advanced about 20% so far this year.

Via The Motley Fool

2 Top Healthcare Stocks Defying the Bear Market ↗

July 11, 2023

These stocks are rising in the double digits -- and outperforming the S&P 500.

Via The Motley Fool

Sitting on Cash? These 2 Stocks Are Great Buys ↗

July 11, 2023

Coca-Cola and Vertex Pharmaceuticals are excellent choices to add to your portfolio for the long term.

Via The Motley Fool

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

37 38 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.